SCHEMBL18845941

SCHEMBL18845941

CC1(C)c2ccccc2-c2c1ccc1c(-c3cccc(-c4cc(-c5ccccc5)nc(-c5ccccc5)n4)c3)nc3ccccc3c21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.34
KMT2A Q03164 7/20 0.34
MAPT P10636 6/20 0.34
ALDH1A1 P00352 5/20 0.34
HPGD P15428 4/20 0.34
LMNA P02545 3/20 0.34
KDM4E B2RXH2 2/20 0.34
GLA P06280 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
ACACA Q13085 2/20 0.33
NTSR1 P30989 1/20 0.33
THRB P10828 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ATM Q13315 1/20 0.32
ACHE P22303 1/20 0.32
ADORA2A P29274 4/20 0.31
ADORA1 P30542 3/20 0.31
ADORA3 P0DMS8 2/20 0.31
ABCB1 P08183 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18846054 0.98 MEN1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18846057 0.97 MEN1 (0.34) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18845806 0.94 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18845735 0.94 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18845877 0.93 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18845930 0.93 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18845712 0.93 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18845871 0.93 MEN1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19530550 0.89 MEN1 (0.35) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18845710 0.87 ATM (0.44) MEN1KMT2AMAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446765-B2 Heterocyclic compound and organic light emitting element using same HEESUNG MATERIAL LTD. (KR) 2019-10-15 US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME CRY1, CRY2, PER2 MEN1 1034/4885KMT2A 579/4885MAPT 1917/4885
US-10446765-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, PER2 MEN1 1034/4885KMT2A 579/4885MAPT 1917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.